SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-050229
Filing Date
2013-09-23
Accepted
2013-09-23 16:12:23
Documents
1
Period of Report
2013-09-19

Document Format Files

Seq Description Document Type Size
1 DIRECTOR ANNUAL GRANT rrd391039.html 4  
1 DIRECTOR ANNUAL GRANT rrd391039.xml 4 3755
  Complete submission text file 0001181431-13-050229.txt   5303
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40919 ENCYCLOPEDIA CIRCLE FREMONT CA 94538
Business Address
WANG SUSAN (Reporting) CIK: 0001246409 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 131110279